Why the study?
What is the frequency of malfunction in nonthoracotomy implantable cardioverter defibrillators, and what is the value of chest radiography in determining the cause?
What is the frequency of malfunction in nonthoracotomy implantable cardioverter defibrillators, and what is the value of chest radiography in determining the cause?
Malfunction of nonthoracotomy implantable cardioverter-defibrillators is infrequent (6%), and chest radiography is a valuable tool for identifying the cause in the majority of cases.
Answers are grounded in this paper and cite their sources.
Supports chest radiography to identify most ICD malfunctions; leaves open impact on outcomes or surveillance protocols.
OBJECTIVE: The purpose of this study was to determine the frequency of system malfunction in patients with nonthoracotomy implantable cardioverter defibrillators and to assess the role of chest radiography in detecting and determining the cause of malfunction. MATERIALS AND METHODS: The study population consisted of 300 consecutive patients in whom implantable cardioverter defibrillators were implanted using an initial nonthoracotomy approach between September 1990 and October 1994. Transvenous electrodes were placed via the subclavian or cephalic vein under local anesthetic. Intraoperative testing, pulse generator implantation, and, if necessary, subcutaneous patch or extrapericardial patch placement via thoracotomy were done in the operating room under general anesthetic. Follow-up consisted of routine device interrogation every 2-3 months and annual chest radiography. Chest radiographs were obtained more often if patients were symptomatic or if results of device interrogation were abnormal. RESULTS: Patients were followed up for a mean +/- SD of 19 +/- 14 months following implantation. Implantable cardioverter-defibrillator malfunction occurred in 17 patients (6%) during the follow-up period. Of these, 12 (71%) had component abnormalities on chest radiographs. Patients with radiographically apparent implantable cardioverter-defibrillator abnormalities presented in two discrete time periods after device implantation, early (mean, 35 +/- 14 days) and late (mean, 18 +/- 5 months). CONCLUSION: Malfunction of nonthoracotomy implantable cardioverter-defibrillator systems develops infrequently after device implantation. In most cases, the cause can be identified on chest radiographs.
No takes yet. Share an insight, caveat, or question.
Drucker et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: